Drug
Femoston
Femoston is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph not_applicable
3
60%
Ph phase_1
1
20%
Ph phase_4
1
20%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
3(60.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(2)
Other(3)
Detailed Status
unknown3
Completed2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (20.0%)
Phase 41 (20.0%)
N/A3 (60.0%)
Trials by Status
completed240%
unknown360%
Recent Activity
0 active trials
Showing 5 of 5
unknownnot_applicable
QXZS in Menopausal Syndrome Based on 16S rRNA Sequencing Technology
NCT06143696
completednot_applicable
Clinical Efficacy of Qingxin Zishen Decoction in Treating Menopausal Syndrome and Neuroendocrine Mechanism of Regulating KNDy Neurons
NCT06132620
unknownphase_4
Clinical Observation on Kuntai Capsule in Treating Early-onset Ovarian Hypofunction
NCT05021094
completedphase_1
Comparison of Different Doses of Oestrogen Therapy for Preventing Intrauterine Adhesion
NCT02726971
unknownnot_applicable
Efficiency of Amnion Graft to Prevent Intrauterine Adhesions After Hysteroscopic Surgery
NCT02132104
Clinical Trials (5)
Showing 5 of 5 trials
NCT06143696Not Applicable
QXZS in Menopausal Syndrome Based on 16S rRNA Sequencing Technology
NCT06132620Not Applicable
Clinical Efficacy of Qingxin Zishen Decoction in Treating Menopausal Syndrome and Neuroendocrine Mechanism of Regulating KNDy Neurons
NCT05021094Phase 4
Clinical Observation on Kuntai Capsule in Treating Early-onset Ovarian Hypofunction
NCT02726971Phase 1
Comparison of Different Doses of Oestrogen Therapy for Preventing Intrauterine Adhesion
NCT02132104Not Applicable
Efficiency of Amnion Graft to Prevent Intrauterine Adhesions After Hysteroscopic Surgery
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5